Richard Bungay
Chief Executive Officer
Immunology
Chroma Therapeutics
United Kingdom
Biography
Richard Bungay joined Chroma in October 2004 as Chief Financial Officer and became CEO in July 2012. He had been Director of Corporate Communications and Strategic Planning at Celltech since September 2000, with responsibility for investor and media relations, corporate M&A activity and strategic planning. Prior to this he held several senior financial positions at AstraZeneca, and before that was group financial controller at Celltech. He holds a BSc in Chemistry from Nottingham University and is a qualified Chartered Accountant.
Research Interest
Chemistry, Accountant.
